The Surgical Management of Dermato Fibro Sarcoma Protuberance

The Surgical Management Of Dermato Fibro Sarcoma Protuberance

Authors

  • Dr. K A Bhadreshwara
  • Dr. K D Parmar
  • Dr. B H Dave
  • Dr. H L Leuva

DOI:

https://doi.org/10.70284/njirm.v5i4.776

Keywords:

Dermatofibrosarcoma protuberance, wide local excision, Recurrence

Abstract

Background: Dermatofibrosarcoma protuberance is relatively uncommon low to intermediate grade malignant neoplasm with characteristic cytogenetic features. It constitutes less than 0.1% of all malignant neoplasms. Although metastasized rarely, it is locally aggressive tumour with high recurrence rate. It is a one of the rare type of law grade sarcomas that occur s anywhere in the body, usually arise from trunks and extremities. It rarely arises from abdominal wall. Objectives: The main objective of the present study was to study the outcome of surgical treatment of dermatofibrosarcoma protuberance. Methods: This study included 4 patients all retrospective and prospective from September 2008 to December 2013. They were subjected to detailed history taking and examination with relevant investigations and were subjected to surgery. They were followed up for at least 36-month period to assess for any recurrence. Results and Interpretation: Out of 4 patients, all were males. Mean age of presentation was 32 years. Site distribution was 25% trunk, 50% extremities and 25% neck. All patients underwent wide local excision. At the end of follow-up period of up to 3 years after surgery Overall recurrence rate was nil. Because of the potential of local recurrence, therapy for DFSP should be directed toward adequate local excision of the primary lesion. Minimal resection should include a surrounding margin, comprising 3-cm margin of normal skin and removal of underlying deep fascia. Compromising on margins invites higher chances of local recurrence. Conclusion: DFSP behaves like a locally infiltrating neoplasm. Despite their locally aggressive behaviour, distant metastasis occurs with extreme rarity. Because of this, it is reasonable that therapy should be directed towards adequate local excision of the primary lesion. Compromising on margins always invites higher chances of local recurrence. [Bhadreshwara K NJIRM 2014; 5(4):98-101]

References

1. Saudi Med J. 2004 Dec; 25(12):2016-7.Links
2. Hoffert PW. Dermatofibrosarcoma protuberans: A review of the literature and presentation of three cases. Surgery. 1952; 31:705–15.
3. McPeak CJ, Cruz T, Nicastri AD. Dermatofibrosarcoma Protuberans: An analysis of 86 cases-Five with metastasis. Ann Surg. 1967; 166:803–16. [PMC free article]
4. Angouridakis N, Kafas P, Jerjes W, Triaridis S, Upile T, Karkavelas G, et al. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck. Head and Neck Oncol. 2011; 3:5. [PMC free article]
5. Pack GT, Tabah EJ. Dermatofibrosarcoma protuberans: A report of 39 cases. AMA Arch Surg. 1951; 62:391–411.
6. Eisen RN, Tallini G. Metastatic dermatofibrosarcoma protuberans with fibrosarcomatous change in the absence of local recurrence: A case report of simultaneous occurrence with a malignant giant cell tumour of soft parts. Cancer. 1993; 15:462–68.
7. Arican O, Bakaris S, Bulbuloglu E, Ezberci F. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans. Acta Dermatovenerol Alp Penonica Adriot. 2006; 15:39–44.
8. Rowsell AR, Poole MD, Godfrey AM. Dermatofibrosarcoma protuberans: The problems of surgical management. Br J Plast Surg. 1986; 39:262–4.
9. McGregor JK. Role of surgery in the management of Dermatofibrosarcoma protuberans. Ann Surg. 1961; 154:255–8. [PMC free article]
10. Roses DF, Valensi Q, LaTrenta G, Harris MN. Surgical treatment of Dermatofibrosarcoma Protuberans. Surg Gynecol Obstet. 1986; 162:449–52.
11. Taylor HB, Helwig EB. Dermatofibrosarcoma Protuberans: A study of 115 cases. Cancer. 1962; 15:717–25.
12. Brenner W, Schaefler K, Chhabra H, Postel A. Dermatofibrosarcoma Protuberans metastatic to regional lymph node: Report of a case and review. Cancer. 1975; 36:1897–902.
13. Jambhekar NA, Chinoy RC. Dermatofibrosarcoma protuberans-Experience at a cancer hospital in India. Indian J Cancer. 88; 25:94–103.
14. Burkhardt BR, Soule EH, Winkelmann RK, Ivins JC. Dermatofibrosarcoma protuberans: Study of fifty six cases. Am J Surg. 1966; 111:638–44.
15. Phelan JT, Juardo J. Dermatofibrosarcoma Protuberans. Am J Surg. 1963; 106:943–8.
16. Lindner NJ, Scarborough MT, Powell GJ, Spanier S, Enneking WF. Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol. 1999; 25:392–7.
17. Rutgers EJ, Kroon BB, Albus-Lutter CE, Gortzak E. Dermatofibrosarcoma protuberans: Treatment and prognosis. Eur J Surg Oncol. 1992; 18:241–8.
18. Cai H, Wang Y, Wu J, Shi Y. Dermatofibrosarcoma protuberans: Clinical diagnoses and treatment results of 260 cases in China. J Surg Oncol. 2012; 105:142–8.

Downloads

Published

2018-01-04

How to Cite

Bhadreshwara, D. K. A., Parmar, D. K. D., Dave, D. B. H., & Leuva, D. H. L. (2018). The Surgical Management of Dermato Fibro Sarcoma Protuberance: The Surgical Management Of Dermato Fibro Sarcoma Protuberance. National Journal of Integrated Research in Medicine, 5(4), 99–102. https://doi.org/10.70284/njirm.v5i4.776

Issue

Section

Case Report